Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease
Yanhua Chen, Xiaomeng Du, Annapurna Kuppa, et al.
Nature Genetics (2023) Vol. 55, Iss. 10, pp. 1640-1650
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK Biobank
Antonino Oliveri, Ryan Rebernick, Annapurna Kuppa, et al.
Nature Genetics (2024) Vol. 56, Iss. 2, pp. 212-221
Open Access | Times Cited: 40
Natural history and progression of metabolic dysfunction-associated steatotic liver disease
Hannes Hagström, Ying Shang, Hannes Hegmar, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 10, pp. 944-956
Closed Access | Times Cited: 30
Diabetes mellitus—Progress and opportunities in the evolving epidemic
E. Dale Abel, Anna L. Gloyn, Carmella Evans‐Molina, et al.
Cell (2024) Vol. 187, Iss. 15, pp. 3789-3820
Closed Access | Times Cited: 27
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease
David Martí‐Aguado, José Luís Calleja, Eduardo Vilar‐Gómez, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. 930-940
Closed Access | Times Cited: 25
What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside
Pojsakorn Danpanichkul, Kanokphong Suparan, Donghee Kim, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 1, pp. 278-278
Open Access | Times Cited: 21
Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment
Norbert Stefan, Hannele Yki‐Järvinen, Brent A. Neuschwander‐Tetri
The Lancet Diabetes & Endocrinology (2024)
Open Access | Times Cited: 16
A Comprehensive Review of the Genetics of Dyslipidemias and Risk of Atherosclerotic Cardiovascular Disease
Megan Kalwick, Mendel Roth
Nutrients (2025) Vol. 17, Iss. 4, pp. 659-659
Open Access | Times Cited: 1
Whole-genome sequencing of half-a-million UK Biobank participants
Shuwei Li, Keren Carss, Bjarni V. Halldórsson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 33
What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
Giovanni Tarantino, Vincenzo Citro
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort
Vincent Chen, Xiaomeng Du, Antonino Oliveri, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 379-388
Open Access | Times Cited: 12
Genetics of MASLD: The State of Art Update.
Silvia Sookoian, Yaron Rotman, Luca Valenti
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 11, pp. 2177-2187.e3
Closed Access | Times Cited: 11
Differing genetic variants associated with liver fat and their contrasting relationships with cardiovascular diseases and cancer
Altayeb Ahmed, Madeleine Cule, Jimmy D. Bell, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. 921-929
Open Access | Times Cited: 10
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease
Oveis Jamialahmadi, Antonio De Vincentis, Federica Tavaglione, et al.
Nature Medicine (2024)
Open Access | Times Cited: 10
Insulin resistance is an integral feature of MASLD even in the presence of PNPLA3 variants
Fernando Bril, Srilaxmi Kalavalapalli, Romina Lomonaco, et al.
JHEP Reports (2024) Vol. 6, Iss. 7, pp. 101092-101092
Open Access | Times Cited: 8
The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes
Lana Bridi, Saaket Agrawal, Kaleb Tesfai, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 3, pp. 369-377
Closed Access | Times Cited: 7
Fatty liver disease protective MTARC1 p.A165T variant reduces the protein stability of MTARC1
Mengyue Wu, Meng Tie, Liwei Hu, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 702, pp. 149655-149655
Open Access | Times Cited: 6
Machine learning across multiple imaging and biomarker modalities in the UK Biobank improves genetic discovery for liver fat accumulation
Hari Somineni, Sumit Mukherjee, David Amar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
The Intersection of Genetic Factors, Aberrant Nutrient Metabolism and Oxidative Stress in the Progression of Cardiometabolic Disease
Andrew Butcko, Ashley K. Putman, Emilio P. Mottillo
Antioxidants (2024) Vol. 13, Iss. 1, pp. 87-87
Open Access | Times Cited: 5
Recent advances in MASLD genetics: Insights into disease mechanisms and the next frontiers in clinical application
Vincent Chen, Graham F. Brady
Hepatology Communications (2025) Vol. 9, Iss. 1
Open Access
Genetics of liver disease in adults
Chigoziri Konkwo, Shanin Chowdhury, Sílvia Vilarinho
Hepatology Communications (2024) Vol. 8, Iss. 4
Open Access | Times Cited: 4
The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review
Charles Leahy, Nicholas J. Osborne, Leticia Shirota, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116241-116241
Closed Access | Times Cited: 4
NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review
Consolato Sergi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8462-8462
Open Access | Times Cited: 4
Adipocyte inflammation is the primary driver of hepatic insulin resistance in a human iPSC-based microphysiological system
Lin Qi, Marko Groeger, Aditi Sharma, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Genetic predisposition of metabolic dysfunction-associated steatotic liver disease: a population-based genome-wide association study
Shaowen Wang, C. H. Wang, Yu‐Ming Cheng, et al.
Hepatology International (2025)
Open Access
Genetic risk amplifies lifestyle effects on hepatic steatosis and its progression: Insights from a population-based cohort
Xin Zhang, Haili Wang, Chengnan Guo, et al.
Digestive and Liver Disease (2025)
Closed Access
Page 1 - Next Page

Scroll to top